VisMederi Holding
Improving human health
VISMEDERI TEXTYLE SRL
Qualified Centre capable of carrying out all the main analyses necessary to certify the quality of textile materials, as well as the conformity and quality of raw materials and semi-finished products in the tanning sector with the verification of CITES certificates through DNA analysis.
tttt
tttt
tttt
tttt
tttt
tttt
tttt
tttt
tttt
tttt
tttt
tttt
Vismederi Group
The Group of Vismederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Srl.
Vismederi Holding
VisMederi is today a solid reality that grew year after year in credibility, customer portfolio, human resources and economic results. These are the results of prolific work carried out by a motivated, young and highly competent group, which has found in VisMederi not only a job but also a great opportunity for professional growth.
Revenues
EmployeesÂ
Global Partnerships
Vismederi Holding: last news
All the news of the group
Bundibugyo ebolavirus: supporting vaccine development for an emerging public health threat
VisMederi Expands Its Service Portfolio with End-to-End Sample Kit Management
VisMederi and CEVAC Sign Memorandum of Understanding to Strengthen Vaccine Clinical Trial Capabilities in Europe
VisMederi and KingMylab Sign Strategic Partnership to Strengthen Global Clinical Trial Testing Services for Vaccines and Biologics
VisMederi signs vaccine research partnership with GCCL at World Vaccine Congress 2026
Universal influenza vaccine candidate, collaboration with Sumitomo Pharma Co., Ltd. and Japan’s National Institutes of Biomedical Innovation Health and Nutrition (NIBN)
VisMederi is a partner in the EU-selected NOFLU consortium supporting early clinical development of a next-generation pandemic influenza vaccine
VisMederi steps up Nipah readiness as India reports a new signal in West Bengal.
VisMederi drives progress toward the 100 Days Mission through CEPI’s world-leading network
New scientific publication: “High-dose influenza vaccine: enhanced protection for the elderly”
Where we
are
The
founder
Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.